Sanolla, an Israel-based medical device and technology start-up, has been granted EU funding under the Horizon 2020 programme to help address coronavirus pandemic. After its earlier announcement, Sanolla shifted its technology to support the early detection and monitoring of Covid-19, enabling doctors to quickly evaluate and diagnose patients with its artificial intelligence based smart auscultation device. Sanolla set up a consortium with seven European entities and companies. Sanolla and its partners have been granted a total of €5m funding for the project, under the Horizon 2020 programme.
Meridian Bioscience, a provider of diagnostic testing solutions, has announced the launch of a novel SARS-CoV-2 antibody pair to the trimeric spike protein to speed up development of Covid-19 assays from patient saliva. Coronavirus-neutralizing antibodies mainly target the trimeric spike (S) glycoprotein on the viral surface that mediates entry into the host cell. This antibody pair binds to recombinant SARS-CoV-2 trimeric spike protein.
Go deeper with GlobalData
Many countries in Europe have begun testing a technology platform that will enable national coronavirus tracing apps to ‘talk’ to one another in order to better address the Covid-19 pandemic. The European Commission has begun test runs between the servers that support the apps made by the Denmark, Germany, Czech Republic, Ireland, Latvia and Italy. These apps not only share a similar design but also exchange data between them, reported Reuters.
Canada-based LuminUltra has submitted its GeneCount Covid-19 RT-qPCR Assay Kit (Covid-19 Assay) to the US FDA for emergency use authorisation (EUA) and to Health Canada for an interim order (IO). This authorisation will enable LuminUltra to provide a complete clinical Covid-19 testing solution that can be customised for testing facilities across North America.
